Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06388525
Other study ID # PostERCPLC
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2016
Est. completion date January 1, 2020

Study information

Verified date April 2024
Source Kanuni Sultan Suleyman Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In this retrospective study, we aimed to detect of effects of ERCP on outcomes of Laparoscopic Cholecystectomy. Patients underwent elective cholecystectomy surgery with a diagnosis of symptomatic cholelithiasis were identified and divided into two main groups regarding to have a ERCP procedure prior to surgery or not. To eliminate possible differences in baseline characteristics, patients in ERCP and non-ERCP groups were propensity score-matched 1:1 using nearest-neighbor matching without replacement based on age, sex and ASA score. Following propensity score matching (PSM), the ERCP and non-ERCP groups were first compared to detect effects of the ERCP procedure itself. After comparison of two main groups, subgroup analyzes performed for the ERCP group to detect effect of ERCP-related variables (indication for ERCP procedure, time between last ERCP procedure and surgery, number of preoperative ERCPs, stone extractions, and biliary stent use)


Description:

All patients aged 18 years and over who underwent elective cholecystectomy surgery with a diagnosis of symptomatic cholelithiasis and whose surgery was started laparoscopically in a single tertiary reference hospital between January 1, 2016 and January 1, 2020 were identified retrospectively using the hospital data. Patients with a diagnosis of malignancy, with a history of percutaneous cholecystostomy, who underwent cholecystectomy while being operated for a different indication, and those who were diagnosed with cholecystoenteric fistula during the operation, were excluded from the study. After exclusion, patients first divided to two groups regarding to have a ERCP procedure prior to surgery or not. Age, sex, ASA scores, history of previous abdominal surgery, Charlson Comorbidity Index (CCI) values were included as baseline data. In terms of CCI scores, patients categorized into two subgroups according to CCI scores greater than 3 or not. To eliminate possible differences in baseline characteristics, patients were propensity score-matched 1:1 using nearest-neighbor matching without replacement based on age, sex and American Society of Anesthesiologists (ASA) score. Following propensity score matching (PSM), the ERCP and non-ERCP groups were first compared to detect effects of the ERCP procedure itself. The primary outcomes examined in our study were conversion to open and subtotal cholecystectomy, intraoperative adhesion levels and operative time, hospital stay and postoperative complications. Only complications that have a Clavien-Dindo Score greater or equal to 3 were noted as postoperative complication for analyzes. While the patients with no adhesions were considered as group A, the patients with adhesions covering less than 50% of the gallbladder were considered as group B, whereas the patients in whom the gallbladder was completely covered with adhesions were considered as group C. After comparison of two main groups, subgroup analyzes performed for the ERCP group to detect effect of ERCP-related variables to the same outcomes. The variables used in each separate subgroup analysis in the ERCP group were as follows: indication for ERCP procedure, time between last ERCP procedure and surgery, number of preoperative ERCPs, stone extractions, and biliary stent use. Information about mechanical lithotripsy was also noted and used for a separate subgroup analysis For the first subgroups analysis, ERCP group divided into two subgroups regarding the preoperative ERCP indication was cholangitis or not. The second subgroup analysis was based on the ERCP-Laparoscopic cholecystectomy interval and three subgroups determined. Accordingly, for the timing of surgery, the first two weeks after ERCP were classified as early interval, the 2nd and 6th weeks as moderate interval, and the 6 weeks or later after ERCP, as late interval. Each of the number of preoperative ERCPs, extracted stones, and placed biliary stents were also used determinants for shaping the other subgroups. For the design of the last subgroup, patients were divided into two subgroups according to whether or not they had mechanical lithotripsy in their preoperative ERCP.


Recruitment information / eligibility

Status Completed
Enrollment 426
Est. completion date January 1, 2020
Est. primary completion date January 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - All patients aged 18 years and over who underwent elective cholecystectomy surgery with a diagnosis of symptomatic cholelithiasis and whose surgery was started laparoscopically Exclusion Criteria: - Patients with a diagnosis of malignancy, with a history of percutaneous cholecystostomy, who underwent cholecystectomy while being operated for a different indication, and those who were diagnosed with cholecystoenteric fistula during the operation, were excluded from the study.

Study Design


Related Conditions & MeSH terms

  • Endoscopic Retrograde Cholangiopancreatography

Intervention

Procedure:
Endoscopic Retrograde Cholangiopancreatography


Locations

Country Name City State
Turkey Bakirkoy Dr. Sadi Konuk Training and Research Hospital Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Kanuni Sultan Suleyman Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Conversion to open Decision to continue with conventional open surgery despite laparoscopic initiation 2016-2020
Primary Subtotal Cholecystectomy Decision to complete the procedure with a subtotal cholecystectomy, despite an initial goal of a total cholecystectomy 2016-2020
Primary Postoperative Complications Any postoperative complications that have a Clavien-Dindo Score greater than or equal to 3 2016-2020
Primary Adhesion levels Perivesical adhesion status based on descriptions of omental adhesion levels defined by Sugrue et al. 2016-2020
Primary Operative time Duration of surgical procedure itself 2016-2020
Primary Length of hospital stay Time spent in hospital until discharge 2016-2020
See also
  Status Clinical Trial Phase
Completed NCT02548884 - Pancreatic Sphincterotomy Versus Double Wire Technique in Difficult Cannulation N/A
Completed NCT04325152 - Clip-assisted Fixation to Prevent Migration of Fully Covered Self-expandable Metal Stent in Patients Undergoing ERCP N/A
Completed NCT01505218 - Propofol Patient-controlled Sedation for Endoscopic Retrograde Cholangiopancreatography N/A
Completed NCT00867204 - Short Versus Long Wire ERCP Systems N/A
Completed NCT03707613 - Learning Curve of Double-wire Cannulation Technique During Endoscopic Retrograde Cholangiopancreatography (ERCP) N/A
Withdrawn NCT03353181 - Application of Endoscopic Scissors Cutting ENBD Tube in the Treatment of Malignant Hilar Biliary Strictures N/A
Completed NCT05122858 - EUS-guided Biliary Drainage of First Intent With the Lumen Apposing Metal Stent vs. ERCP in the Management of Malignant Distal Biliary Obstruction (AXIOS-CPRE) N/A
Completed NCT03550768 - Effect of Anatomy of Major Duodenal Papilla on the Difficulty of Cannulation During Endoscopic Retrograde Cholangiopancreatography
Recruiting NCT04903444 - Development and Validation of an Artificial Intelligence-based Biliary Stricture Navigation System in MRCP-based ERCP N/A
Completed NCT04103749 - Global Prospective Case Series Using a Single-Use Duodenoscope N/A
Completed NCT04609917 - Difficult Cannulation Criteria in Trainee Involved ERCP Cannulation
Recruiting NCT05947461 - Prevention of Post-ERCP Pancreatitis by Indomethacin vs Diclofenac N/A
Completed NCT04143698 - Reusable Versus Disposable Duodenoscopes for ERCP N/A
Completed NCT02992652 - Allopurinol in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis N/A
Completed NCT01079312 - Patient-controlled Sedation With Propofol and Remifentanyl for Endoscopic Retrograde Cholangiopancreatography (ERCP) Phase 4
Completed NCT04223830 - Initial Case Series With Exalt Single-Use Duodenoscope - Expanded User Experience N/A
Recruiting NCT06277414 - a Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Complication
Recruiting NCT03413111 - Modified Double Wire Technique to Facilitate the Successful Cannulation N/A
Terminated NCT03057769 - Effect of Papillary Epinephrine Spraying on Post-ERCP Pancreatitis in Patients Received Rectal Indomethacin N/A
Recruiting NCT01745978 - Compare the Knob-tipped Knife With the Needle Knife in Difficult Biliary Cannulation Phase 3